Payment overview · 2025
General Payments
$16.42
1 reported records · 1 companies
Healthcare provider profile · identity verified
Bryan D Hooker, MD
Allopathic & Osteopathic Physicians|Internal Medicine · JASPER, GA · NPI 1083600605
Verified facts
What the public records show
CMS Open Payments records show Bryan D Hooker, MD received $16.42 in general payments during 2025 across 1 reported records.
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $16.42 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $16.42 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16.42 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Lisinopril | Lisinopril | 448 | 108 |
| Amlodipine Besylate | Amlodipine Besylate | 435 | 106 |
| Levothyroxine Sodium | Levothyroxine Sodium | 409 | 99 |
| Alprazolam | Alprazolam | 388 | 59 |
| Atorvastatin Calcium | Atorvastatin Calcium | 388 | 101 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 291 | 75 |
| Gabapentin | Gabapentin | 275 | 62 |
| Omeprazole | Omeprazole | 261 | 64 |
| Pantoprazole Sodium | Pantoprazole Sodium | 249 | 67 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 245 | 85 |
| Trazodone Hcl | Trazodone Hcl | 220 | 62 |
| Methylprednisolone | Methylprednisolone | 216 | 152 |
| Tamsulosin Hcl | Tamsulosin Hcl | 213 | 50 |
| Duloxetine Hcl | Duloxetine Hcl | 195 | 46 |
| Metoprolol Tartrate | Metoprolol Tartrate | 167 | 35 |
| Metformin Hcl Er | Metformin Hcl | 166 | 48 |
| Meloxicam | Meloxicam | 165 | 59 |
| Escitalopram Oxalate | Escitalopram Oxalate | 150 | 38 |
| Pregabalin | Pregabalin | 148 | 47 |
| Quetiapine Fumarate | Quetiapine Fumarate | 147 | 38 |
| Carvedilol | Carvedilol | 146 | 36 |
| Furosemide | Furosemide | 146 | 47 |
| Metformin Hcl | Metformin Hcl | 142 | 46 |
| Potassium Chloride | Potassium Chloride | 133 | 52 |
| Lorazepam | Lorazepam | 130 | 40 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 124 | 31 |
| Ozempic | Semaglutide | 124 | 32 |
| Hydrochlorothiazide | Hydrochlorothiazide | 120 | 37 |
| Citalopram Hbr | Citalopram Hydrobromide | 116 | 27 |
| Famotidine | Famotidine | 115 | 34 |
| Clopidogrel | Clopidogrel Bisulfate | 111 | 23 |
| Prednisone | Prednisone | 108 | 45 |
| Eliquis | Apixaban | 106 | 23 |
| Simvastatin | Simvastatin | 105 | 26 |
| Metoprolol Succinate | Metoprolol Succinate | 104 | 29 |
| Clonidine Hcl | Clonidine Hcl | 101 | 27 |
| Sertraline Hcl | Sertraline Hcl | 101 | 23 |
| Pravastatin Sodium | Pravastatin Sodium | 100 | 21 |
| Mirtazapine | Mirtazapine | 99 | 24 |
| Montelukast Sodium | Montelukast Sodium | 98 | 28 |
| Clonazepam | Clonazepam | 97 | 20 |
| Ropinirole Hcl | Ropinirole Hcl | 97 | 24 |
| Buspirone Hcl | Buspirone Hcl | 93 | 24 |
| Celecoxib | Celecoxib | 93 | 26 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 93 | 62 |
| Oxcarbazepine | Oxcarbazepine | 90 | 31 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 86 | 18 |
| Fluticasone Propionate | Fluticasone Propionate | 81 | 31 |
| Paroxetine Hcl | Paroxetine Hcl | 80 | 14 |
| Fluoxetine Hcl | Fluoxetine Hcl | 79 | 19 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 76 | 20 |
| Ondansetron Odt | Ondansetron | 72 | 33 |
| Tizanidine Hcl | Tizanidine Hcl | 72 | 30 |
| Aripiprazole | Aripiprazole | 70 | 16 |
| Losartan Potassium | Losartan Potassium | 69 | 25 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 66 | 60 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 65 | 16 |
| Atenolol | Atenolol | 63 | 13 |
| Donepezil Hcl | Donepezil Hcl | 63 | 14 |
| Jardiance | Empagliflozin | 61 | 13 |
| Allopurinol | Allopurinol | 60 | 18 |
| Amitriptyline Hcl | Amitriptyline Hcl | 60 | suppressed |
| Lamotrigine | Lamotrigine | 59 | 12 |
| Topiramate | Topiramate | 58 | 17 |
| Diclofenac Sodium | Diclofenac Sodium | 57 | 19 |
| Glipizide | Glipizide | 57 | 15 |
| Memantine Hcl | Memantine Hcl | 56 | 11 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 54 | 24 |
| Levofloxacin | Levofloxacin | 54 | 46 |
| Ezetimibe | Ezetimibe | 52 | 13 |
| Glimepiride | Glimepiride | 52 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 52 | 12 |
| Azithromycin | Azithromycin | 51 | 45 |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 50 | 50 |
| Fluconazole | Fluconazole | 49 | 28 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 47 | 34 |
| Doxepin Hcl | Doxepin Hcl | 47 | 11 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 47 | 17 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 47 | 17 |
| Nortriptyline Hcl | Nortriptyline Hcl | 47 | 14 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 44 | 12 |
| Tramadol Hcl | Tramadol Hcl | 43 | 19 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 42 | 17 |
| Methocarbamol | Methocarbamol | 41 | 21 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 41 | 36 |
| Bupropion Xl | Bupropion Hcl | 40 | 12 |
| Levetiracetam | Levetiracetam | 38 | suppressed |
| Finasteride | Finasteride | 37 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 36 | 13 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 36 | 24 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 36 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 36 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 35 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 34 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 34 | 12 |
| Hydralazine Hcl | Hydralazine Hcl | 32 | suppressed |
| Spironolactone | Spironolactone | 32 | suppressed |
| Cephalexin | Cephalexin | 31 | 23 |
| Sucralfate | Sucralfate | 31 | suppressed |
| Valsartan | Valsartan | 31 | 12 |
| Divalproex Sodium Er | Divalproex Sodium | 30 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 29 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 28 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 28 | suppressed |
| Januvia | Sitagliptin Phosphate | 27 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 27 | 14 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 25 | suppressed |
| Ranolazine Er | Ranolazine | 25 | suppressed |
| Baclofen | Baclofen | 24 | suppressed |
| Glipizide Er | Glipizide | 24 | suppressed |
| Novolog Flexpen | Insulin Aspart | 23 | suppressed |
| Ibuprofen | Ibuprofen | 22 | suppressed |
| Linzess | Linaclotide | 21 | suppressed |
| Nitroglycerin | Nitroglycerin | 21 | 16 |
| Propranolol Hcl | Propranolol Hcl | 21 | suppressed |
| Kapspargo Sprinkle | Metoprolol Succinate | 20 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 20 | suppressed |
| Synthroid | Levothyroxine Sodium | 20 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 19 | suppressed |
| Dutasteride | Dutasteride | 19 | suppressed |
| Novolog | Insulin Aspart | 19 | suppressed |
| Vascepa | Icosapent Ethyl | 19 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 18 | 14 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 18 | suppressed |
| Myrbetriq | Mirabegron | 18 | suppressed |
| Risperidone | Risperidone | 18 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 18 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 18 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 17 | suppressed |
| Olanzapine | Olanzapine | 17 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 17 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 17 | suppressed |
| Chlorthalidone | Chlorthalidone | 16 | suppressed |
| Nifedipine Er | Nifedipine | 16 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 15 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 15 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 15 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 15 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Trulicity | Dulaglutide | 15 | suppressed |
| Xarelto | Rivaroxaban | 15 | suppressed |
| Estradiol | Estradiol | 14 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 14 | suppressed |
| Ketoconazole | Ketoconazole | 14 | 13 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 14 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 14 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 13 | 12 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 13 | suppressed |
| Lansoprazole | Lansoprazole | 13 | suppressed |
| Metolazone | Metolazone | 13 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 13 | 13 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 13 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 12 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 12 | suppressed |
| Colchicine | Colchicine | 12 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 12 | suppressed |
| Entresto | Sacubitril/Valsartan | 12 | suppressed |
| Lidocaine | Lidocaine | 12 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 12 | suppressed |
| Modafinil | Modafinil | 12 | suppressed |
| Nystatin | Nystatin | 12 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 12 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 12 | suppressed |
| Acyclovir | Acyclovir | 11 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 11 | suppressed |
| Cefdinir | Cefdinir | 11 | 11 |
| Dicyclomine Hcl | Dicyclomine Hcl | 11 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 11 | suppressed |
| Levemir | Insulin Detemir | 11 | suppressed |
| Minoxidil | Minoxidil | 11 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 11 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 11 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 11 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $16.42 · 1 records | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error